Since the introduction of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in 2018. Malawi has achieved national coverage of trained providers in the public sector and steady increases in uptake of DMPA-SC. However. the rate of clients opting to self-inject DMPA-SC has remained lower than early acceptability studies suggested. https://www.chiggate.com/3m-speedglas-9002nc-welding-helmet-fashion/